Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| OneMedNet CorpONMD · Entity 9052 | Director · 10% owner | October 07, 2026 | October 14, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
OneMedNet Corp
Report date October 07, 2026 · Filed October 14, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 1,983,573 |
Reported balance
After 2026-10-07 transaction · row 1
1 source rowRow 1 · 2026-10-07 · Purchase · Acquired 129,758 · Balance 1,983,573 F1: On October 7, 2026, the issuer entered into a subscription agreement with the reporting person for a $750,000 investment in the issuer. F2: The shares were valued at the volume-weighted average price (VWAP) of the issuer for the 10 trading days immediately prior to the purchase date. |
Filing footnotes · ownership attribution and instrument terms
F1: On October 7, 2026, the issuer entered into a subscription agreement with the reporting person for a $750,000 investment in the issuer.
F2: The shares were valued at the volume-weighted average price (VWAP) of the issuer for the 10 trading days immediately prior to the purchase date.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| October 07, 2026 Filed Oct 14, 2026 00:32 UTC | OneMedNet Corp ONMD · Entity 9052 | PurchaseCommon Stock | 129,758 | $5.78 | $750,001.24 |
DisclosureSEC source: 0001493152-26-046909 · ownership.xml · nonDerivative · entry 1 Kosasa Thomas · CIK 0001989846 · Director · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,983,573 F1 · kind: On October 7, 2026, the issuer entered into a subscription agreement with the reporting person for a $750,000 investment in the issuer. F2 · price: The shares were valued at the volume-weighted average price (VWAP) of the issuer for the 10 trading days immediately prior to the purchase date. Read SEC document |
| July 30, 2026 Filed Aug 7, 2026 21:20 UTC | OneMedNet Corp ONMD · Entity 9052 | PurchaseCommon Stock | 1,449,275 | $0.69 | $999,999.75 |
DisclosureSEC source: 0001493152-26-036660 · ownership.xml · nonDerivative · entry 1 Kosasa Thomas · CIK 0001989846 · Director · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 18,538,150 F1 · kind: On July 30, 2026, the issuer entered into a subscription agreement with the reporting person for a $1,000,000 investment in the issuer. F2 · price: The shares were valued at the volume-weighted average price (VWAP) of the issuer for the 10 trading days immediately prior to the purchase date. Read SEC document |
| June 12, 2026 Filed Jun 15, 2026 10:09 UTC | OneMedNet Corp ONMD · Entity 9052 | PurchaseCommon Stock | 158,730 | $0.63 | $99,999.90 |
DisclosureSEC source: 0001493152-26-028585 · ownership.xml · nonDerivative · entry 1 Kosasa Thomas · CIK 0001989846 · Director · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 17,088,874 F1 · kind: On June 12, 2026, the issuer entered into a subscription agreement with the reporting person for a $100,000 investment in the issuer. F2 · price: The shares were valued at the volume-weighted average price (VWAP) of the issuer for the 10 trading days immediately prior to the purchase date. Read SEC document |
| May 18, 2026 Filed May 20, 2026 20:51 UTC | OneMedNet Corp ONMD · Entity 9052 | PurchaseCommon Stock | 268,817 | $0.93 | $249,999.81 |
DisclosureSEC source: 0001493152-26-024642 · ownership.xml · nonDerivative · entry 1 Kosasa Thomas · CIK 0001989846 · Director · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 16,930,144 F1 · kind: On May 18, 2026, the issuer entered into a subscription agreement with the reporting person for a $250,000 investment in the issuer. F2 · price: The shares were valued at the volume-weighted average price (VWAP) of the issuer for the 10 trading days immediately prior to the purchase date. Read SEC document |
| April 23, 2026 Filed Apr 24, 2026 12:40 UTC | OneMedNet Corp ONMD · Entity 9052 | PurchaseCommon Stock | 280,898 | $0.89 | $249,999.22 |
DisclosureSEC source: 0001493152-26-018860 · ownership.xml · nonDerivative · entry 2 Kosasa Thomas · CIK 0001989846 · Director · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 16,661,327 F3 · kind: On April 23, 2026, the issuer entered into a subscription agreement with the reporting person for a $250,000 investment in the issuer. F2 · price: The shares were valued at the volume-weighted average price for the 10 trading days immediately prior to the applicable purchase date. Read SEC document |
| February 06, 2026 Filed Apr 24, 2026 12:40 UTC | OneMedNet Corp ONMD · Entity 9052 | PurchaseCommon Stock | 595,238 | $0.84 | $499,999.92 |
DisclosureSEC source: 0001493152-26-018860 · ownership.xml · nonDerivative · entry 1 Kosasa Thomas · CIK 0001989846 · Director · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 16,380,429 F1 · kind: On February 6, 2026, the issuer entered into a subscription agreement with the reporting person for a $500,000 investment in the issuer. F2 · price: The shares were valued at the volume-weighted average price for the 10 trading days immediately prior to the applicable purchase date. Read SEC document |
| November 26, 2025 Filed Nov 27, 2025 02:54 UTC | OneMedNet Corp ONMD · Entity 9052 | GrantCommon Stock | 45,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001493152-25-025277 · ownership.xml · nonDerivative · entry 10 Kosasa Thomas · CIK 0001989846 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 15,785,191 F7 · shares: Represents RSUs granted as director compensation under the 2022 Plan for board service in fiscal year 2025. The RSUs vest on December 31, 2025, subject to the reporting person's continued service with the issuer through the vesting date. Read SEC document |
| September 24, 2025 Filed Nov 27, 2025 02:54 UTC | OneMedNet Corp ONMD · Entity 9052 | PurchaseCommon Stock | 6,000 | $0.93 | $5,598.60 |
DisclosureSEC source: 0001493152-25-025277 · ownership.xml · nonDerivative · entry 9 Kosasa Thomas · CIK 0001989846 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 15,740,191 Read SEC document |
| August 29, 2025 Filed Nov 27, 2025 02:54 UTC | OneMedNet Corp ONMD · Entity 9052 | PurchaseCommon Stock | 581,395 | $0.86 | $499,999.70 |
DisclosureSEC source: 0001493152-25-025277 · ownership.xml · nonDerivative · entry 8 Kosasa Thomas · CIK 0001989846 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 15,734,191 F6 · shares: On August 29, 2025, the issuer entered into a subscription agreement with the reporting person, pursuant to which the issuer agreed to sell 581,395 shares of common stock to the reporting person at a purchase price of $0.86 per share, totaling $500,000 in gross proceeds to the issuer. Read SEC document |
| June 20, 2025 Filed Nov 27, 2025 02:54 UTC | OneMedNet Corp ONMD · Entity 9052 | PurchaseCommon Stock | 1,190,476 | $0.42 | $499,999.92 |
DisclosureSEC source: 0001493152-25-025277 · ownership.xml · nonDerivative · entry 7 Kosasa Thomas · CIK 0001989846 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 15,152,796 F5 · shares: On June 20, 2025, the issuer entered into a subscription agreement with the reporting person, pursuant which the issuer agreed to sell 1,190,476 shares of common stock to the reporting person at a purchase price of $0.42 per share, totaling $500,000 in gross proceeds to the issuer. Read SEC document |
| June 19, 2025 Filed Nov 27, 2025 02:54 UTC | OneMedNet Corp ONMD · Entity 9052 | ConversionCommon Stock | 2,865,016 | $0.71 | $2,034,161.36 |
DisclosureSEC source: 0001493152-25-025277 · ownership.xml · nonDerivative · entry 6 Kosasa Thomas · CIK 0001989846 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 13,962,320 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · shares: On June 19, 2025, the issuer entered into an agreement with the reporting person to convert an aggregate of approximately $2.0 million of outstanding principal and accrued interest under certain shareholder loans and business combination extension loans. Read SEC document |
| June 19, 2025 Filed Nov 27, 2025 02:54 UTC | OneMedNet Corp ONMD · Entity 9052 | ConversionCommon Stock | 2,123,424 | $0.75 | $1,598,938.27 |
DisclosureSEC source: 0001493152-25-025277 · ownership.xml · nonDerivative · entry 5 Kosasa Thomas · CIK 0001989846 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 11,097,304 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · shares: On June 19, 2025, the reporting person delivered notice of his election to convert in full the amounts of outstanding principal under certain convertible shareholder loans previously made by the reporting person to the issuer, in an aggregate principal amount of approximately $1.6 million. Read SEC document |
| June 17, 2025 Filed Nov 27, 2025 02:54 UTC | OneMedNet Corp ONMD · Entity 9052 | ConversionSenior Secured Convertible Note · Derivative | 493,056 | Not disclosed Strike: $1.14 | Not disclosed |
DisclosureSEC source: 0001493152-25-025277 · ownership.xml · derivative · entry 11 Kosasa Thomas · CIK 0001989846 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 493,056 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: On June 28, 2023, Data Knights Acquisition Corp. ("Data Knights") (the predecessor of the issuer) and certain investors, including the reporting person (collectively, the "Purchasers"), entered into a securities purchase agreement pursuant to which Data Knights issued and sold to the Purchasers senior secured convertible notes (the "PIPE Notes"), which are convertible into shares of common stock at each Purchasers' election, at a conversion price equal to the lower of (i) $10.00 per share, or (ii) 92.5% of the lowest volume weighted average trading price for the ten (10) trading days immediately preceding the conversion date, subject to a floor price of $1.14. The PIPE Notes matured on the first anniversary of the issuance date (November 7, 2024), subject to extension pursuant to the terms of the PIPE Notes. The conversion shares included accrued interest from the date of issuance. F2 · price: On June 28, 2023, Data Knights Acquisition Corp. ("Data Knights") (the predecessor of the issuer) and certain investors, including the reporting person (collectively, the "Purchasers"), entered into a securities purchase agreement pursuant to which Data Knights issued and sold to the Purchasers senior secured convertible notes (the "PIPE Notes"), which are convertible into shares of common stock at each Purchasers' election, at a conversion price equal to the lower of (i) $10.00 per share, or (ii) 92.5% of the lowest volume weighted average trading price for the ten (10) trading days immediately preceding the conversion date, subject to a floor price of $1.14. The PIPE Notes matured on the first anniversary of the issuance date (November 7, 2024), subject to extension pursuant to the terms of the PIPE Notes. The conversion shares included accrued interest from the date of issuance. F2 · derivative.exercise_date: On June 28, 2023, Data Knights Acquisition Corp. ("Data Knights") (the predecessor of the issuer) and certain investors, including the reporting person (collectively, the "Purchasers"), entered into a securities purchase agreement pursuant to which Data Knights issued and sold to the Purchasers senior secured convertible notes (the "PIPE Notes"), which are convertible into shares of common stock at each Purchasers' election, at a conversion price equal to the lower of (i) $10.00 per share, or (ii) 92.5% of the lowest volume weighted average trading price for the ten (10) trading days immediately preceding the conversion date, subject to a floor price of $1.14. The PIPE Notes matured on the first anniversary of the issuance date (November 7, 2024), subject to extension pursuant to the terms of the PIPE Notes. The conversion shares included accrued interest from the date of issuance. F2 · derivative.expiration_date: On June 28, 2023, Data Knights Acquisition Corp. ("Data Knights") (the predecessor of the issuer) and certain investors, including the reporting person (collectively, the "Purchasers"), entered into a securities purchase agreement pursuant to which Data Knights issued and sold to the Purchasers senior secured convertible notes (the "PIPE Notes"), which are convertible into shares of common stock at each Purchasers' election, at a conversion price equal to the lower of (i) $10.00 per share, or (ii) 92.5% of the lowest volume weighted average trading price for the ten (10) trading days immediately preceding the conversion date, subject to a floor price of $1.14. The PIPE Notes matured on the first anniversary of the issuance date (November 7, 2024), subject to extension pursuant to the terms of the PIPE Notes. The conversion shares included accrued interest from the date of issuance. F2 · derivative.underlying_shares: On June 28, 2023, Data Knights Acquisition Corp. ("Data Knights") (the predecessor of the issuer) and certain investors, including the reporting person (collectively, the "Purchasers"), entered into a securities purchase agreement pursuant to which Data Knights issued and sold to the Purchasers senior secured convertible notes (the "PIPE Notes"), which are convertible into shares of common stock at each Purchasers' election, at a conversion price equal to the lower of (i) $10.00 per share, or (ii) 92.5% of the lowest volume weighted average trading price for the ten (10) trading days immediately preceding the conversion date, subject to a floor price of $1.14. The PIPE Notes matured on the first anniversary of the issuance date (November 7, 2024), subject to extension pursuant to the terms of the PIPE Notes. The conversion shares included accrued interest from the date of issuance. Read SEC document |
| June 17, 2025 Filed Nov 27, 2025 02:54 UTC | OneMedNet Corp ONMD · Entity 9052 | ConversionCommon Stock | 493,056 | $1.14 | $562,083.84 |
DisclosureSEC source: 0001493152-25-025277 · ownership.xml · nonDerivative · entry 4 Kosasa Thomas · CIK 0001989846 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,973,880 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · shares: On June 28, 2023, Data Knights Acquisition Corp. ("Data Knights") (the predecessor of the issuer) and certain investors, including the reporting person (collectively, the "Purchasers"), entered into a securities purchase agreement pursuant to which Data Knights issued and sold to the Purchasers senior secured convertible notes (the "PIPE Notes"), which are convertible into shares of common stock at each Purchasers' election, at a conversion price equal to the lower of (i) $10.00 per share, or (ii) 92.5% of the lowest volume weighted average trading price for the ten (10) trading days immediately preceding the conversion date, subject to a floor price of $1.14. The PIPE Notes matured on the first anniversary of the issuance date (November 7, 2024), subject to extension pursuant to the terms of the PIPE Notes. The conversion shares included accrued interest from the date of issuance. Read SEC document |
| June 16, 2025 Filed Nov 27, 2025 02:54 UTC | OneMedNet Corp ONMD · Entity 9052 | PurchaseCommon Stock | 55,000 | $0.38 | $21,015.50 |
DisclosureSEC source: 0001493152-25-025277 · ownership.xml · nonDerivative · entry 3 Kosasa Thomas · CIK 0001989846 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,480,824 Read SEC document |
| April 21, 2025 Filed Nov 27, 2025 02:54 UTC | OneMedNet Corp ONMD · Entity 9052 | PurchaseCommon Stock | 47,000 | $0.49 | $22,860.80 |
DisclosureSEC source: 0001493152-25-025277 · ownership.xml · nonDerivative · entry 2 Kosasa Thomas · CIK 0001989846 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,425,824 Read SEC document |
| January 19, 2024 Filed Nov 27, 2025 02:54 UTC | OneMedNet Corp ONMD · Entity 9052 | GrantCommon Stock | 45,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001493152-25-025277 · ownership.xml · nonDerivative · entry 1 Kosasa Thomas · CIK 0001989846 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,378,824 F1 · shares: Represents restricted stock units ("RSUs") granted as director compensation under the OneMedNet Corporation 2022 Equity Incentive Plan (the "2022 Plan") for board service in fiscal year 2024. Each RSU represents the contingent right to receive one share of the issuer's common stock. The RSUs vested on December 31, 2024. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.